Chorioallantoic Membrane Measles: Development and Clinical Evaluation of a New Further Attenuated Measles Vaccine
AUTOR(ES)
Cerini, Costantino P.
RESUMO
A new, further attenuated measles vaccine, developed by propagation of Edmonston B measles virus in the chorioallantoic membrane in ovo, has been clinically evaluated in children and found to compare favorably with a commercially available product. The vaccine is prepared in chick embryo tissue culture and appears to possess noteworthy stability at 4 C.
